BioPharm International, January 2011

Features

By Daryl Fernandes

An approach to biopharmaceutical development that combines Quality by Design with a suite of visual informatics tools to reduce scale-up risks.

By Chitra Sethi

How did biopharmaceutical professionals fare during a year of hiring freezes, high anxiety, and increased workload? Our survey finds out.

By A. Poles Lahille , C. Richard , S. Fisch , D. Pedelaborde , S. Gerby , V. Perrier , D. Balbuena , R. Trieau , L. Valognes , D. Peyret

A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.

Regulatory Beat

By Jill Wechsler

Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.

From the Editor

Following on Follow-Ons

By Michelle Hoffman

So often a leader on the world stage, the US is a laggard when it comes to regulating follow-on biologics.

Final Word

The Case for Insourcing

By Mike Gamble

Why this workforce trend is well-suited for pharmaceutical companies.

Burrill on Biotech

By G. Steven Burrill

Business models that were used to create current value are no longer going to be effective going forward.

Outsourcing Insights

What to Watch For in 2011

By Jim Miller

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.